Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Oxybutynin-induced reflux esophagitis.

M Lee1, R Sharifi

  • 1College of Pharmacy, University of Illinois, Chicago 60612.

DICP : the Annals of Pharmacotherapy
|June 1, 1990
PubMed
Summary

Oxybutynin, often preferred for its lower anticholinergic effects, can paradoxically cause reflux esophagitis by relaxing the lower esophageal sphincter. This case highlights a rare adverse effect of oxybutynin and informs management strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CD8-depleted donor lymphocyte infusion as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation.

Blood·1995
Same author

Effects of putative cannabinoid receptor ligands, anandamide and 2-arachidonyl-glycerol, on immune function in B6C3F1 mouse splenocytes.

The Journal of pharmacology and experimental therapeutics·1995
Same author

Immunogold localization of high-affinity glucose transporter isoforms in normal rat kidney.

Laboratory investigation; a journal of technical methods and pathology·1995
Same author

Jejunal diverticulitis manifesting with abdominal wall abscess.

The American journal of gastroenterology·1995
Same author

Genetic homogeneity in Sjögren-Larsson syndrome: linkage to chromosome 17p in families of different non-Swedish ethnic origins.

American journal of human genetics·1995
Same author

Sequence specificity of alkylation for a series of nitrogen mustard-containing analogues of distamycin of increasing binding site size: evidence for increased cytotoxicity with enhanced sequence specificity.

Biochemistry·1995

Area of Science:

  • Gastroenterology
  • Pharmacology

Background:

  • Oxybutynin is frequently prescribed for overactive bladder due to its reduced anticholinergic activity compared to propantheline bromide.
  • Patients at risk for anticholinergic adverse effects are often candidates for oxybutynin therapy.

Observation:

  • A case of oxybutynin-induced reflux esophagitis is presented.
  • The adverse effect is hypothesized to stem from oxybutynin's anticholinergic properties, specifically its impact on lower esophageal sphincter (LES) tone.

Findings:

  • Oxybutynin's anticholinergic action can lead to decreased lower esophageal sphincter tone.
  • This mechanism can precipitate gastroesophageal reflux disease (GERD) symptoms, manifesting as reflux esophagitis.

Implications:

  • Clinicians should consider reflux esophagitis as a potential adverse effect of oxybutynin.
  • A management approach for oxybutynin-induced esophagitis and similar medication-induced GERD is outlined for clinical practice.

Related Experiment Videos